(NASDAQ: KRRO) Korro Bio's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 45.66%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 42.83%.
Korro Bio's earnings in 2025 is -$88,417,000.On average, 12 Wall Street analysts forecast KRRO's earnings for 2025 to be -$88,788,141, with the lowest KRRO earnings forecast at -$95,058,176, and the highest KRRO earnings forecast at -$85,038,174. On average, 12 Wall Street analysts forecast KRRO's earnings for 2026 to be -$74,475,736, with the lowest KRRO earnings forecast at -$164,183,004, and the highest KRRO earnings forecast at -$49,243,036.
In 2027, KRRO is forecast to generate -$84,296,091 in earnings, with the lowest earnings forecast at -$159,383,951 and the highest earnings forecast at -$29,466,716.